Juvisé Pharmaceuticals - Arimidex & Casodex - Ownership and Business Overview

Life ScienceCompany

Juvisé Pharmaceuticals - Arimidex & Casodex Ownership

Who owns Juvisé Pharmaceuticals - Arimidex & Casodex?

Juvisé Pharmaceuticals - Arimidex & Casodex is owned by Juvisé Pharmaceuticals. It was acquired on December 20, 2019.

Juvisé Pharmaceuticals - Arimidex & Casodex Business Overview

Where is Juvisé Pharmaceuticals - Arimidex & Casodex headquartered?

Juvisé Pharmaceuticals - Arimidex & Casodex is headquartered in Villeurbanne, France.

What sector is Juvisé Pharmaceuticals - Arimidex & Casodex in?

Juvisé Pharmaceuticals - Arimidex & Casodex is a life science company.

Life Science M&A Summary in 2019

Out of 60 sectors in the Mergr database, life science ranked 9 in number of deals in 2019. The largest life science acquisition in 2019 was Celgene - which was acquired by Bristol-Myers Squibb for $74.0B.

Join Mergr to view all 253 acquisitions of life science companies in 2019, including 46 acquisitions by private equity firms, and 207 by strategics.

Juvisé Pharmaceuticals - Arimidex & Casodex

Villeurbanne, 69100
France,

Juvisé Pharmaceuticals - Arimidex & Casodex business Arimidex is an aromatase inhibitor, indicated primarily for the adjuvant treatment of postmenopausal women with hormone receptor-positive early breast cancer, the first-line treatment of postmenopausal women with hormone receptor-positive or hormone receptor-unknown locally advanced or metastatic breast cancer and the treatment of advanced breast cancer in postmenopausal women with disease progression, following tamoxifen therapy. Casodex® (bicalutamide) is an androgen-receptor inhibitor, indicated for use in combination therapy with a luteinising hormone-releasing hormone analogue for the treatment of Stage D2 metastatic carcinoma of the prostate.


Company Summary

SECTOR

Life Science

 Subscribe to unlock this and 209,497
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More
1 Week Free Trial Learn More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB

Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.6K Private Equity Firms
  • 202K M&A Transactions
  • 205K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 81K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.

Related Lists for Juvisé Pharmaceuticals - Arimidex & Casodex

Life Science Companies , France Companies

Related Lists for Life Science Companies

Largest Life Science Companies , Acquisitive Life Science Companies , Recently Acquired Life Science Companies , Recently Sold Life Science Companies , Private Life Science Companies , Public Life Science Companies , Acquired Life Science Companies , PE Backed Life Science Companies

Related Lists for France Companies

Largest France Companies , Acquisitive France Companies , Recently Acquired France Companies , Recently Sold France Companies , Private France Companies , Public France Companies , Acquired France Companies , PE Backed France Companies
Mergr

Product

Company

Legal